10 High-Protein Oatmeal Breakfasts to Help You Lose Weight with GLP-1 Medications
Benefits of a healthy breakfast include increasing energy and keeping you full for hours. It can also help with weight management.
Exploring Weight Management and Obesity Strategies at the California Association of Health Plans Event
The 2023 California Association of Health Plans conference was an innovative and collaborative experience for the California healthcare industry.
Employers Must Brace for 2024 GLP-1 Cost Conundrum
The surge in employee demand for GLP-1 medications has presented organizations with an ongoing dilemma of coverage. And this will be exacerbated with the looming arrival of oral GLP-1s3 that will like
Managing Food Cravings on Your Weight Loss Journey with GLP-1 Medications
Here’s what you should know about the science of cravings, how GLP-1 medications may affect cravings, and tips for managing cravings in healthy ways.
3-Day Meal Plan for Weight Loss on GLP-1 Medications
These tips can also help you feel better and establish healthier habits throughout your weight loss journey and beyond.
Leveraging Digital Health and AI for a Holistic GLP-1 Strategy
Watch this webinar to learn how to leverage AI to combine clinician-guided medication management, patient behavior change, and remote monitoring to improve outcomes.
3 Tips for Employers To Manage High Costs of GLP-1s
According to a recent survey by Business Group on Health, 92% of large employers say they are concerned about high drug costs as a larger driver of healthcare cost trends.
Lark Health Expands Weight Management Program to Support Guided GLP-1 Care Delivery
Dr. Peter Antall, former Amwell CMO, joins Lark as Chief Medical Officer and President, Medical Networks as part of clinical expansion.
A Transformative Time for Healthcare: The AI and GLP-1 Revolution
Watch the discussion on how best to use technology and new drugs to responsibly apply to improve care and impact costs.
Weight Loss Drug Demand Must Be Addressed With New Solutions & Strategies
As the demand for GLP-1 medications continues to soar, health plans and employers must develop a weight management strategy that balances the clinical indications with the financial implications.